Canada markets open in 4 hours 32 minutes

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
200.78+7.40 (+3.83%)
At close: 04:00PM EST
200.78 0.00 (0.00%)
After hours: 07:53PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close193.38
Bid0.00 x 1100
Ask0.00 x 800
Day's Range197.55 - 204.86
52 Week Range118.18 - 309.06
Avg. Volume271,280
Market Cap20.853B
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Motley Fool

    Why Shares of BeiGene Were Up Wednesday

    Shares of Chinese pharmaceutical BeiGene (NASDAQ: BGNE) rose as high as 12.8% in early trading on Wednesday. BeiGene didn't make any big announcements, and its earnings report was back on Nov. 9, so the move was curious. Most likely, it was just a little bit of a return to normalcy after the stock took a beating when there were protests in China regarding the country's strict lockdown "zero tolerance" provisions regarding COVID-19.

  • Simply Wall St.

    In the wake of BeiGene, Ltd.'s (NASDAQ:BGNE) latest US$2.9b market cap drop, institutional owners may be forced to take severe actions

    Every investor in BeiGene, Ltd. ( NASDAQ:BGNE ) should be aware of the most powerful shareholder groups. The group...

  • Motley Fool

    Is This Chinese Pharmaceutical Stock Worth the Risk?

    BeiGene (NASDAQ: BGNE), is a Chinese biopharmaceutical company with offices in Cambridge, Massachusetts; Basel, Switzerland; and Beijing. It focuses on unique therapies to treat cancer, specializing in B-cell malignancies and solid tumors in lung and gastrointestinal cancers. Amid delisting concerns, a lot of Chinese stocks have fallen this year.